Dr. Schul will be taking another patient advocacy role for medicare beneficiaries with venous disorders by sharing the current vein registries and what they offer to helping address questions in epidemiology and clinical outcomes as and advisory committee to Centers for Medicare & Medicaid services meet on Wednesday.
From the American College of Phlebology HQ: As part of a larger coalition of organizations dedicated to evidence-based care of venous disease, the ACP will present at the CMS Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) meeting next Wednesday, July 20, 2016. The meeting will focus on treatment strategies for patients with lower extremity chronic venous disease. Dr. Schul’s discussion about the ACPPROVein registry and data capture process to address current evidence gaps is critical to the future of medicine.
The ACPPROVein Registry currently has 97 National Provider IDs in 86 offices tied to using the database. At last count, there are 10,645 unique patients, and over 40 thousand encounters. Currently StreamLineMD & Medstreaming have had data sets validated to easily merge with the registry. Aprima, eClinicalWorks, & AthenaHealth are also in talks or contracted to become registry compatible. The unique features of the ACPPROVein registry involve the elimination of duplicate entry for providers, AND the additional of adding the patient’s voice to the experience and outcomes perceived. This is current day medicine where outcomes may be tied to procedures and performance. Dr. Schul’s advocacy commitment led to the birth of the ACPPROVein registry, and now late in its infancy the data is starting to grow at a staggering pace.
The meeting is being live-streamed through the CMS website. To tune in, please use the link below.
To read the ACP press release about the meeting, please CLICK HERE
July, 20, 2016
7:30 AM – 4:30 PM EST